Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Disease × vistusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 2 Solid Tumor 2 Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Meningioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Estrogen Receptor Positive Breast Cancer 1 Endometrial Neoplasms 1 Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Advanced Cancer 1 Adenocarcinoma 1

Interventions

Blood Specimen Collection 8 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Colonoscopy 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Prednisone 3 Mammography 3 Magnetic Resonance Imaging 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 weifuchun 2 Urination 2 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Methods 2 Melphalan 2 Immunohistochemistry 2 Gemcitabine 2 Dexamethasone 2 Dermoscopy 2 Cyclophosphamide 2 Clinical Laboratory Techniques 2 vistusertib 1 venetoclax 1 tivozanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02064608 2019-07-17

CaNCaP02

Cambridge University Hospitals NHS Foundation Trust

Phase 1 Completed

Disease, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡